Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
November 14, 2022 at 06:45 pm IST
Share
Bal Pharma Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 753.07 million compared to INR 671.73 million a year ago. Revenue was INR 753.55 million compared to INR 677.31 million a year ago. Net income was INR 1.14 million compared to INR 13.79 million a year ago. Basic earnings per share from continuing operations was INR 0.07 compared to INR 0.97 a year ago. Diluted earnings per share from continuing operations was INR 0.07 compared to INR 0.97 a year ago.
For the six months, sales was INR 1,451.47 million compared to INR 1,379.98 million a year ago. Revenue was INR 1,464.37 million compared to INR 1,386.94 million a year ago. Net income was INR 3.96 million compared to INR 30.01 million a year ago. Basic earnings per share from continuing operations was INR 0.26 compared to INR 2.11 a year ago. Diluted earnings per share from continuing operations was INR 0.26 compared to INR 2.11 a year ago.
Bal Pharma Limited is a fully integrated pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. It offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The Company offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.